brimonidine tartrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ALPHAGAN brimonidine tartrate 2mg/mL eye drop bottle
AUST R: 60297
Active ingredients:
brimonidine tartrate

Dosage form:
Eye Drops, solution

Sponsor:
Abbvie Pty Ltd

Phone:
1800 043 460

From
12 Aug 2026
to
17 Aug 2026

Shortage status:
Resolved

Availability:
Available

Reason:
Unexpected increase in consumer demand
ALPHAGAN P 1.5 brimonidine tartrate 0.15% eye drop bottle
AUST R: 158888
Active ingredients:
brimonidine tartrate

Dosage form:
Eye Drops, solution

Sponsor:
Abbvie Pty Ltd

Phone:
1800 043 460

Deletion from market:
31 Jan 2026

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
The sponsor is transitioning to the new formulation of ALPHAGAN P 1.0 brimonidine tartrate 1 mg/mL eye drop bottle (ARTG 421114). This product will be available from February 2026.